6 MAR709 had finished its Phase 2a clinical trial in 2017, 51 and it is a balanced dual agonist for GLP-1R and GIPR
American Heart Association - Heart Palpitations Information : Comprehensive patient resource on what heart palpitations are, when to seek care, and how to distinguish benign palpitations from concerning ones
According to GoodRx, a company that operates a telemedicine platform that tracks drug prices and provides drug coupons for discounts, the number of people with no commercial insurance coverage for Zepbound (tirzepatide) increased by over 180% in 2025
Common triggers include stress, illness, poor diet, hormonal changes, and environmental factors
Epigenet & Chromatin
One adverse event led to withdrawal from the study: a non-serious drug hypersensitivity event of moderate severity with onset 12 days after IcoSema administration, duration of 5 days, assessed by the investigator to be possibly related to study product and with an outcome of recovered/resolved